3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
5
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Neoplasm Metastasis
1
Metastatic Gastroesophageal Junction Adenocarcinoma
1
Colorectal Cancer Liver Metastasis
1
Cholangiocarcinoma
1
Advanced Metastatic Gastric Cancer
1
Interventions
Gemcitabine
2
Everolimus
2
sintilimab
1
Vitamin D
1
S 1 (combination)
1
Radiofrequency Ablation
1
Radiation
1
Photochemotherapy
1
Neoadjuvant Therapy
1
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
Congresses as Topic
1
Capecitabine
1
Calcitriol
1
Ambulatory Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Cholangiocarcinoma
×
sintilimab
×
Clear all
NCT05207735
2022-01-26
SCRCA
Henan Cancer Hospital
Phase 2
Unknown
73 enrolled